Recent advancements in nanotechnology have led to the development of several successful vaccines:
The Pfizer-BioNTech COVID-19 vaccine uses lipid nanoparticles to deliver mRNA encoding the spike protein of the SARS-CoV-2 virus. Moderna's COVID-19 vaccine similarly employs lipid nanoparticles for mRNA delivery. Research is ongoing into nanoparticle-based vaccines for diseases like influenza, malaria, and cancer.
